The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery

BMC Surgery

Volumn 11, Issue , 2011, Pages

  Bökkerink, Guus M J ^a   De Graaf, Eelco J R ^b   Punt, Cornelis J A ^a   Nagtegaal, Iris D ^a   Rütten, Heidi ^a   Nuyttens, Joost J M E ^c   Van Meerten, Esther ^c   Doornebosch, Pascal G ^b   Tanis, Pieter J ^d   Derksen, Eric J ^e   Dwarkasing, Roy S ^c   Marijnen, Corrie A M ^f   Cats, Annemieke ^g   Tollenaar, Rob A E M ^f   De Hingh, Ignace H J T ^h   Rutten, Harm J T ^h   Van Der Schelling, George P ⁱ   Ten Tije, Albert J ⁱ   Leijtens, Jeroen W A ^j   Lammering, Guido ^k   Beets, Geerard L ^l   Aufenacker, Theo J ^m   Pronk, Apollo ⁿ   Manusama, Eric R ^o   Hoff, Christiaan ^o   Bremers, Andreas J A ^a   Verhoef, Cornelelis ^c   De Wilt, Johannes H W ^a   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IJSSELLAND HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e SLOTERVAART HOSPITAL   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^h CATHARINA HOSPITAL   (Netherlands)

ⁱ AMPHIA HOSPITAL   (Netherlands)

^j LAURENTIUS HOSPITAL   (Netherlands)

^k MAASTRO CLINIC   (Netherlands)

^l MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^m Department of Surgery   (Netherlands)

ⁿ Daniel Den Hoed Cancer Center ^*  (Netherlands)

^o Medical Centre   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MICROSURGERY; MIDDLE AGED; MULTICENTER STUDY; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; NOSE; PROSPECTIVE STUDY; RADIATION EXPOSURE; RECTUM; RECTUM TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSURGERY; MIDDLE AGED; NATURAL ORIFICE ENDOSCOPIC SURGERY; NOSE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; TREATMENT OUTCOME;

EID: 84857993166     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-11-34     Document Type: Article

References (49)

1. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Kapiteijn E, Marijnen CA, Colenbrander AC, Klein Kranenbarg E, Steup WH, van Krieken JH, van Houwelingen JC, Leer JW, van de Velde CJ, Eur J Surg Oncol 1998 24 6 528 535 10.1016/S0748-7983(98)93500-4 9870729 (Pubitemid 28566899)
2. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, et al. N Engl J Med 2001 345 9 638 646 10.1056/NEJMoa010580 11547717
3. Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Kim NK, Aahn TW, Park JK, Lee KY, Lee WH, Sohn SK, Min JS, Dis Colon Rectum 2002 45 9 1178 1185 10.1007/s10350-004-6388-5 12352233
4. Managing rectal cancer: the Dutch experience. Peeters KC, Kapiteijn E, van de Velde CJ, Colorectal Dis 2003 5 5 423 426 10.1046/j.1463-1318.2003.00513. x 12925073 (Pubitemid 37080647)
5. A meta-analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer. Cornish JA, Tilney HS, Heriot AG, Lavery IC, Fazio VW, Tekkis PP, Ann Surg Oncol 2007 14 7 2056 2068 10.1245/s10434-007-9402-z 17431723 (Pubitemid 46988269)
6. Chemotherapy with preoperative radiotherapy in rectal cancer. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, N Engl J Med 2006 355 11 1114 1123 10.1056/NEJMoa060829 16971718 (Pubitemid 44394918)
7. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, et al. J Clin Oncol 2006 24 28 4620 4625 10.1200/JCO.2006.06.7629 17008704 (Pubitemid 46630960)
8. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Kim DW, Lim SB, Kim DY, Kim TH, Jung KH, Kim DH, Chang HJ, Sohn DK, Hong CW, Choi HS, et al. Eur J Surg Oncol 2006 32 2 162 167 10.1016/j.ejso.2005.10.002 16289718 (Pubitemid 43257117)
9. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J, Ann Surg 2001 234 5 633 640 10.1097/00000658- 200111000-00008 11685026 (Pubitemid 33041766)
10. Preoperative versus postoperative chemoradiotherapy for rectal cancer. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al. N Engl J Med 2004 351 17 1731 1740 10.1056/NEJMoa040694 15496622 (Pubitemid 39383208)
11. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Stipa F, Chessin DB, Shia J, Paty PB, Weiser M, Temple LK, Minsky BD, Wong WD, Guillem JG, Ann Surg Oncol 2006 13 8 1047 1053 10.1245/ASO.2006.03.053 16865595 (Pubitemid 44337963)
12. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, Cellini F, Barbaro B, Cogliandolo S, Nuzzo G, et al. Int J Radiat Oncol Biol Phys 2002 53 3 664 674 10.1016/S0360-3016(02)02764-5 12062610 (Pubitemid 34626505)
13. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, et al. Int J Radiat Oncol Biol Phys 1999 44 5 1027 1038 10.1016/S0360-3016(99)00099-1 10421535 (Pubitemid 29342903)
14. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, Calvo FA, Garcia-Aguilar J, Glynne-Jones R, Haustermans K, et al. Lancet Oncol 2010 11 9 835 844 10.1016/S1470-2045(10)70172-8 20692872
15. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M, Dis Colon Rectum 2004 47 11 1798 1807 10.1007/s10350-004-0681-1 15622571 (Pubitemid 40064422)
16. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J, Ann Surg 2004 240 4 711 717 discussion 717-718 15383798
17. Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review. Doornebosch PG, Tollenaar RA, De Graaf EJ, Acta Oncol 2009 48 3 343 353 10.1080/02841860802342408 18855161
18. Transanal endoscopic microsurgery: a systematic review. Middleton PF, Sutherland LM, Maddern GJ, DisColon Rectum 2005 48 2 270 284 (Pubitemid 40576558)
19. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. You YN, Baxter NN, Stewart A, Nelson H, AnnSurg 2007 245 5 726 733 (Pubitemid 46684102)
20. Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review. Doornebosch PG, Tollenaar RA, De Graaf EJ, Acta Oncol 2009 48 3 343 353 10.1080/02841860802342408 18855161
21. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. You YN, Baxter NN, Stewart A, Nelson H, Ann Surg 2007 245 5 726 733 10.1097/01.sla.0000252590.95116.4f 17457165 (Pubitemid 46684102)
22. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J, Radiology 2004 232 3 773 783 10.1148/radiol.2323031368 15273331 (Pubitemid 39100263)
23. Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Langer C, Liersch T, Suss M, Siemer A, Markus P, Ghadimi BM, Fuzesi L, Becker H, Int J Colorectal Dis 2003 18 3 222 229 12673487 (Pubitemid 36764168)
24. Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. de Bruin AF, Nuyttens JJ, Ferenschild FT, Planting AS, Verhoef C, de Wilt JH, Neth J Med 2008 66 2 71 76 18292610 (Pubitemid 351279449)
25. Preoperative versus postoperative chemoradiotherapy for rectal cancer. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al. NEnglJMed 2004 351 17 1731 1740 10.1056/NEJMoa040694 (Pubitemid 39383208)
26. Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer. Caricato M, Ausania F, De Dominicis E, Vincenzi B, Rabitti C, Tonini G, Cellini F, Coppola R, Eur J Surg Oncol 2007 33 6 724 728 10.1016/j.ejso.2007.01.023 17336482 (Pubitemid 47033809)
27. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Livingstone JI, McDonald PJ, et al. Int J Colorectal Dis 2006 21 1 11 17 10.1007/s00384-005-0749-y 15864605 (Pubitemid 41829760)
28. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Kim DW, Kim DY, Kim TH, Jung KH, Chang HJ, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG, Cancer 2006 106 8 1694 1700 10.1002/cncr.21794 16532432
29. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG, Kodner IJ, Dis Colon Rectum 2004 47 6 825 831 10.1007/s10350-004-0535-x 15108025 (Pubitemid 38702600)
30. Technique of transanal endoscopic microsurgery. Buess G, Kipfmuller K, Hack D, Grussner R, Heintz A, Junginger T, Surg Endosc 1988 2 2 71 75 10.1007/BF00704356 3413659
31. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van dV, EurJSurg 1999 165 5 410 420 (Pubitemid 29377119)
32. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, et al. NEnglJMed 2001 345 9 638 646 10.1056/NEJMoa010580
33. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Kim DW, Lim SB, Kim DY, Kim TH, Jung KH, Kim DH, Chang HJ, Sohn DK, Hong CW, Choi HS, et al. EurJSurgOncol 2006 32 2 162 167 (Pubitemid 43257117)
34. Managing rectal cancer: the Dutch experience. Peeters KC, Kapiteijn E, van dV, Colorectal Dis 2003 5 5 423 426 10.1046/j.1463-1318.2003.00513.x 12925073 (Pubitemid 37080647)
35. Local excision of early rectal cancer: is transanal endoscopic microsurgery an alternative to radical surgery? Palma P, Horisberger K, Joos A, Rothenhoefer S, Willeke F, Post S, Rev Esp Enferm Dig 2009 101 3 172 178 19388797
36. Local excision of rectal cancer without adjuvant therapy: a word of caution. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA, Ann Surg 2000 231 3 345 351 10.1097/00000658-200003000-00007 10714627 (Pubitemid 30137122)
37. Transanal endoscopic microsurgical excision of pT2 rectal cancer: results and possible indications. Borschitz T, Heintz A, Junginger T, Dis Colon Rectum 2007 50 3 292 301 10.1007/s10350-006-0816-7 17252286 (Pubitemid 46393978)
38. Local excision and postoperative radiotherapy for distal rectal cancer. Benson R, Wong CS, Cummings BJ, Brierley J, Catton P, Ringash J, Abdolell M, Int J Radiat Oncol Biol Phys 2001 50 5 1309 1316 10.1016/S0360-3016(01)01545-0 11483343 (Pubitemid 32727810)
39. Recurrences after transanal excision or transanal endoscopic microsurgery of T1 rectal cancer. Hermsen PE, Nonner J, De Graaf EJ, Doornebosch PG, Minerva Chir 2010 65 2 213 223 20548276
40. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Chakravarti A, Compton CC, Shellito PC, Wood WC, Landry J, Machuta SR, Kaufman D, Ancukiewicz M, Willett CG, Ann Surg 1999 230 1 49 54 10.1097/00000658-199907000-00008 10400036 (Pubitemid 30190364)
41. Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer. Swellengrebel HA, Marijnen CA, Verwaal VJ, Vincent A, Heuff G, Gerhards MF, van Geloven AA, van Tets WF, Verheij M, Cats A, Br J Surg 2011 98 3 418 426 10.1002/bjs.7315 21254020
42. Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified? Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J, Dis Colon Rectum 2008 51 1 10 19; discussion 19-20 10.1007/s10350-007-9080-8 18043968
43. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD, J Am Coll Surg 2002 194 2 131 135 discussion 135-136 10.1016/S1072-7515(01) 01159-0 11848629 (Pubitemid 34118868)
44. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Zmora O, Dasilva GM, Gurland B, Pfeffer R, Koller M, Nogueras JJ, Wexner SD, Dis Colon Rectum 2004 47 10 1607 1612 10.1007/s10350-004-0673-1 15540288 (Pubitemid 39331970)
45. Local excision of rectal cancer afterchemoradiation: feasibility depends on the primary stage. Burger JW, De Graaf EJ, Doornebosch PG, Grunhagen DJ, Biermann K, de Wilt JH, Verhoef C, IntJColorectal Dis 2010
46. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T, Ann Surg Oncol 2008 15 3 712 720 10.1245/s10434-007-9732-x 18163173
47. Pathologic complete response (pCR) to neoadjuvant chemoradiation (CRT) of uT2uN0 rectal cancer (RC) treated by local excision (LE): Results of the ACOSOG Z6041 trial. Garcia-Aguilar J, J Clin Oncol 2010 28 15 suppl abstr 3510
48. Local excision of rectal cancer revisited: ACOSOG protocol Z6041. Ota DM, Nelson H, Ann Surg Oncol 2007 14 2 271 10.1245/s10434-006-9213-7 17103255 (Pubitemid 46175264)
49. Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Marks JH, Valsdottir EB, DeNittis A, Yarandi SS, Newman DA, Nweze I, Mohiuddin M, Marks GJ, Surg Endosc 2009 23 5 1081 1087 10.1007/s00464-009-0326-5 19263164